Journalist: To reconcile the need for profits sufficient to support new drug research with the moral imperative to provide medicines to those who most need them but cannot afford them, some pharmaceutical companies feel justified in selling a drug in rich nations at one price and in poor nations at a much lower price. But this practice is unjustified. A nation with a low average income may still have a substantial middle class better able to pay for new drugs than are many of the poorer citizens
...
...
